PMC Links for Gene (Select 29126) - PMC

Result Filters

Links from Gene

Items: 1 to 20 of 1278

<< First< Prev

Page of 64

Next >Last >>

Select item 113160451.

PD-L1 deglycosylation promotes its nuclear translocation and accelerates DNA double-strand-break repair in cancer

Zhen Shu, Bhakti Dwivedi, Jeffrey M. Switchenko, David S. Yu, Xingming Deng

Nat Commun. 2024; 15: 6830. Published online 2024 Aug 9. doi: 10.1038/s41467-024-51242-8

PMCID:: PMC11316045

Abstract Article PDF–12M

Select item 112333922.

Hsa_circ_0004872 mitigates proliferation, metastasis and immune escape of meningioma cells by suppressing PD-L1

Kuo Chen, Zhengming Huang, Changsheng Liu, Qian Ouyang, Qing Yan, Wei Zheng, Yongkai Huang

Metab Brain Dis. 2024; 39(5): 895–907. Published online 2024 May 21. doi: 10.1007/s11011-024-01345-4

PMCID:: PMC11233392

Abstract Article PDF–7.1M

Select item 111585273.

B7‐H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma

Ryo Yamamoto, Momoko Nishikori, Masaharu Tashima, Tomomi Sakai, Tatsuo Ichinohe, Akifumi Takaori‐Kondo, Katsuyuki Ohmori, Takashi Uchiyama

Cancer Sci. 2009 Nov; 100(11): 2093–2100. Published online 2009 Aug 1. doi: 10.1111/j.1349-7006.2009.01302.x

PMCID:: PMC11158527

Abstract Article PDF–439K

Select item 111535914.

PD-L1 expression in squamous cervical carcinomas of Mozambican women living with or without HIV

Lucília Lovane, Satish Tulsidás, Carla Carrilho, Christina Karlsson

Sci Rep. 2024; 14: 12974. Published online 2024 Jun 5. doi: 10.1038/s41598-024-63595-7

PMCID:: PMC11153591

Abstract Article PDF–1.4M

Select item 111453675.

PD‐L1 regulates tumor proliferation and T‐cell function in NF2‐associated meningiomas

Ying Wang, Chao Zhang, Minjun Yan, Xin Ma, Lairong Song, Bo Wang, Peng Li, Pinan Liu

CNS Neurosci Ther. 2024 Jun; 30(6): e14784. Published online 2024 Jun 3. doi: 10.1111/cns.14784

PMCID:: PMC11145367

Abstract Article PDF–11M

Select item 110449156.

Comparison of programmed death‐ligand 1 expression in adenocarcinoma and squamous cell carcinoma of the cervix in paraffin blocks of patients with cervical cancer

Maryam Sadat Hosseini, Fatemeh Shafizadeh, Mohammad Hashemi Bahremani, Farah Farzaneh, Tahereh Ashrafganjoei, Maliheh Arab, Maryam Talayeh, Fatemeh Jafari, Alireza Abdshah

Cancer Rep (Hoboken) 2024 Apr; 7(4): e2057. Published online 2024 Apr 25. doi: 10.1002/cnr2.2057

PMCID:: PMC11044915

Abstract Article PDF–7.8M

Select item 110304627.

RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cells

Lisa Borkner, Andrew Kaiser, Willeke van de Kasteele, Reinhard Andreesen, Andreas Mackensen, John B. Haanen, Ton N. Schumacher, Christian Blank

Cancer Immunol Immunother. 2010 Aug; 59(8): 1173–1183. Published online 2010 Mar 27. doi: 10.1007/s00262-010-0842-0

PMCID:: PMC11030462

Abstract Article PDF–711K

Select item 110298398.

Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers

Juro Nakanishi, Yoshihiro Wada, Koichiro Matsumoto, Miyuki Azuma, Ken Kikuchi, Shoichi Ueda

Cancer Immunol Immunother. 2007 Aug; 56(8): 1173–1182. Published online 2006 Dec 22. doi: 10.1007/s00262-006-0266-z

PMCID:: PMC11029839

Abstract Article PDF–474K

Select item 110296719.

Expression patterns of programmed death-ligand 1 in esophageal adenocarcinomas: comparison between primary tumors and metastases

Bastian Dislich, Alexandra Stein, Christian A. Seiler, Dino Kröll, Sabina Berezowska, Inti Zlobec, José Galvan, Julia Slotta-Huspenina, Axel Walch, Rupert Langer

Cancer Immunol Immunother. 2017 Jun; 66(6): 777–786. Published online 2017 Mar 13. doi: 10.1007/s00262-017-1982-2

PMCID:: PMC11029671

Abstract Article PDF–1.3M

Select item 1102957710.

Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer

Christian J. Maine, Nor Haslinda Abdul Aziz, Jayanta Chatterjee, Claudia Hayford, Nancy Brewig, Lynsey Whilding, Andrew J. T. George, Sadaf Ghaem-Maghami

Cancer Immunol Immunother. 2014 Mar; 63(3): 215–224. Published online 2013 Dec 3. doi: 10.1007/s00262-013-1503-x

PMCID:: PMC11029577

Abstract Article PDF–562K

Select item 1102897011.

A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients’ survival in gastric cancer

Weili Wang, Ping Liao, Yijing He

Cancer Immunol Immunother. 2017 Oct; 66(10): 1379–1381. Published online 2017 May 24. doi: 10.1007/s00262-017-2017-8

PMCID:: PMC11028970

Article PDF–438K

Select item 1102875112.

PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer

Riki Okita, Ai Maeda, Katsuhiko Shimizu, Yuji Nojima, Shinsuke Saisho, Masao Nakata

Cancer Immunol Immunother. 2017 Jul; 66(7): 865–876. Published online 2017 Mar 25. doi: 10.1007/s00262-017-1986-y

PMCID:: PMC11028751

Abstract Article PDF–1.1M

Select item 1102836713.

Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma

Soo Jeong Nam, Young-Hoon Kim, Ji Eun Park, Young-shin Ra, Shin Kwang Khang, Young Hyun Cho, Jeong Hoon Kim, Chang Ohk Sung

Cancer Immunol Immunother. 2019 Feb; 68(2): 305–318. Published online 2018 Nov 27. doi: 10.1007/s00262-018-2278-x

PMCID:: PMC11028367

Abstract Article PDF–2.5M

Select item 1102831514.

Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas

Lucie Duverger, Amélie Osio, Bernard Cribier, Laurent Mortier, Adèle De Masson, Nicole Basset-Seguin, Céleste Lebbé, Maxime Battistella

Cancer Immunol Immunother. 2019 Jun; 68(6): 951–960. Published online 2019 Apr 5. doi: 10.1007/s00262-019-02334-8

PMCID:: PMC11028315

Abstract Article PDF–926K

Select item 1102824015.

High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients

Johannes Breyer, Ralph M. Wirtz, Wolfgang Otto, Philipp Erben, Thomas S. Worst, Robert Stoehr, Markus Eckstein, Stefan Denzinger, Maximilian Burger, Arndt Hartmann

Cancer Immunol Immunother. 2018 Mar; 67(3): 403–412. Published online 2017 Nov 17. doi: 10.1007/s00262-017-2093-9

PMCID:: PMC11028240

Abstract Article PDF–1.1M

Select item 1102820916.

Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer

Fabio Grizzi, Angelo Castello, Dorina Qehajaj, Luca Toschi, Sabrina Rossi, Daniela Pistillo, Valentina Paleari, Giulia Veronesi, Pierluigi Novellis, Simona Monterisi, Rossana Mineri, Daoud Rahal, Egesta Lopci

Cancer Immunol Immunother. 2019 Sep; 68(9): 1537–1545. Published online 2019 Sep 3. doi: 10.1007/s00262-019-02387-9

PMCID:: PMC11028209

Abstract Article PDF–984K

Select item 1102820717.

High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer

Yusuke Okuma, Tsunekazu Hishima, Jumpei Kashima, Sadamu Homma

Cancer Immunol Immunother. 2018 Mar; 67(3): 495–505. Published online 2017 Dec 14. doi: 10.1007/s00262-017-2103-y

Correction in:: Cancer Immunol Immunother. 2018 Sep; 67(9): 1477–1479.

PMCID:: PMC11028207

Abstract Article PDF–1.8M

Select item 1102768718.

Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor

Valentine Suteau, Alexandre Collin, Philippe Menei, Patrice Rodien, Marie-Christine Rousselet, Claire Briet

Cancer Immunol Immunother. 2020 Oct; 69(10): 2053–2061. Published online 2020 May 22. doi: 10.1007/s00262-020-02611-x

PMCID:: PMC11027687

Abstract Article PDF–1.0M

Select item 1102767319.

Prognostic role of PD-L1 and immune-related gene expression profiles in giant cell tumors of bone

Jasna Metovic, Laura Annaratone, Alessandra Linari, Simona Osella-Abate, Chiara Musuraca, Francesca Veneziano, Chiara Vignale, Luca Bertero, Paola Cassoni, Nicola Ratto, Alessandro Comandone, Giovanni Grignani, Raimondo Piana, Mauro Papotti

Cancer Immunol Immunother. 2020 Sep; 69(9): 1905–1916. Published online 2020 May 6. doi: 10.1007/s00262-020-02594-9

PMCID:: PMC11027673

Abstract Article PDF–1.5M

Select item 1102766620.

PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas

Mario Sanchez-Canteli, Rocio Granda-Díaz, Nagore del Rio-Ibisate, Eva Allonca, Fernando López-Alvarez, Jackeline Agorreta, Irati Garmendia, Luis M. Montuenga, Juana M. García-Pedrero, Juan P. Rodrigo

Cancer Immunol Immunother. 2020 Oct; 69(10): 2089–2100. Published online 2020 May 24. doi: 10.1007/s00262-020-02604-w